Skip to main content
. 2019 Dec 18;10(12):954. doi: 10.1038/s41419-019-2187-8

Fig. 4. Evaluation of prepared radiolabeled tracers in vitro.

Fig. 4

The stability of 125I-antiTLR5 mAb (a) and 125I-IgG (b) in serum and normal saline changes over time. The concentration of the labeled tracer (125I-anti-TLR5 mAb or 125I-IgG) was kept constantly, and increasing concentrations of unlabeled anti-TLR5 mAb were used to compete with the 125I-anti-TLR5 mAb binding (c).